Literature DB >> 2294252

Epidermal growth factor receptor gene analysis in renal cell carcinoma.

L G Gomella1, P Anglard, E R Sargent, C N Robertson, A Kasid, W M Linehan.   

Abstract

The epidermal growth factor receptor binds the mitogens epidermal growth factor and transforming growth factor-alpha. Increased expression of the epidermal growth factor receptor has been noted in many types of tumors and is associated with gene amplification in several including epidermoid carcinoma, lung carcinoma, breast carcinoma and glioblastoma. We have recently observed increased expression of the epidermal growth factor receptor messenger RNA in neoplastic tissue relative to normal kidney tissue from patients with renal cell carcinoma. To determine if epidermal growth factor receptor gene amplification was present in renal cell carcinoma, DNA was extracted from renal cell carcinoma cell lines and from normal kidney and renal cell carcinoma tissues derived from radical nephrectomy specimens from thirty patients. DNA was analyzed by Southern blot hybridization. There was no epidermal growth factor receptor gene amplification detected in the renal cell carcinoma samples studied, indicating the increased epidermal growth factor gene expression observed in renal cell carcinoma does not occur through gene amplification. Unlike other tumors with enhanced epidermal growth factor receptor gene expression, amplification of this gene does not appear to be a common feature of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294252     DOI: 10.1016/s0022-5347(17)39908-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Targeted therapy in renal cancer.

Authors:  Tanya B Dorff; Amir Goldkorn; David I Quinn
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

2.  Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.

Authors:  B Ljungberg; M Gåfvels; J E Damber
Journal:  Urol Res       Date:  1994

3.  Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system.

Authors:  G Reifenberger; J Reifenberger; T Bilzer; W Wechsler; V P Collins
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

4.  Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.

Authors:  Sara García-Alonso; Inés Romero-Pérez; Lucía Gandullo-Sánchez; Luis Chinchilla; Alberto Ocaña; Juan Carlos Montero; Atanasio Pandiella
Journal:  J Exp Clin Cancer Res       Date:  2021-08-16

5.  Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma.

Authors:  J P Kallio; P Hirvikoski; H Helin; P Kellokumpu-Lehtinen; T Luukkaala; T L J Tammela; P M Martikainen
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.